Generex Biotechnology Corporation
GNBT · OTC
4/30/2021 | 1/31/2021 | 10/31/2020 | 7/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -84.8% | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | -218.9% | – | 73.6% | 71.9% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 47,438.5% | – | -10,959.1% | -1,697.2% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 44,566.3% | – | -291.7% | -2,153.8% |
| EPS Diluted | 0.066 | -0.22 | -0.11 | -0.15 |
| % Growth | 129.9% | -100% | 26.7% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |